Universal Health Services Details Executive Compensation, Board Elections, and Shareholder Proposals
summarizeSummary
This definitive proxy statement provides comprehensive details for Universal Health Services' upcoming annual meeting. Key highlights include the strong 2025 financial performance which led to significant executive compensation payouts, with the CEO's total compensation at $16.1 million and a pay ratio of 283:1. Performance-based restricted stock units (PBRSUs) granted in 2023 vested at 150% of target, reflecting strong achievement of financial objectives. The filing also addresses two shareholder proposals: one seeking a report on votes based on "shareholder money at risk" due to the company's dual-class stock structure (where insiders hold 16% ownership but 91% voting power), and another requesting public disclosure of workforce diversity. The Board recommends against both shareholder proposals. Investors should monitor the outcome of these votes and the ongoing implications of the company's governance structure.
check_boxKey Events
-
Annual Meeting Details Announced
The company will hold its virtual Annual Meeting of Stockholders on May 20, 2026, to vote on director elections, executive compensation, auditor ratification, and two shareholder proposals.
-
Executive Compensation and Performance Payouts Detailed
Named Executive Officers received substantial compensation in 2025, with the CEO's total compensation at $16.1 million and a pay ratio of 283:1. Performance-based awards from 2023 vested at 150% of target due to strong financial results.
-
Shareholder Proposal Challenges Dual-Class Voting Structure
A shareholder proposal requests reporting votes based on "shareholder money at risk," drawing attention to the company's dual-class structure where insiders hold 16% ownership but 91% of voting power. The Board recommends against this proposal.
-
Shareholder Proposal on Workforce Diversity Disclosure
Another shareholder proposal seeks public disclosure of workforce diversity, including EEO-1 reports. The Board recommends against this, citing existing commitments and data limitations.
auto_awesomeAnalysis
This definitive proxy statement provides comprehensive details for Universal Health Services' upcoming annual meeting. Key highlights include the strong 2025 financial performance which led to significant executive compensation payouts, with the CEO's total compensation at $16.1 million and a pay ratio of 283:1. Performance-based restricted stock units (PBRSUs) granted in 2023 vested at 150% of target, reflecting strong achievement of financial objectives. The filing also addresses two shareholder proposals: one seeking a report on votes based on "shareholder money at risk" due to the company's dual-class stock structure (where insiders hold 16% ownership but 91% voting power), and another requesting public disclosure of workforce diversity. The Board recommends against both shareholder proposals. Investors should monitor the outcome of these votes and the ongoing implications of the company's governance structure.
في وقت هذا الإيداع، كان UHS يتداول عند ١٨٦٫٧٦ US$ في NYSE ضمن قطاع Industrial Applications And Services، مع قيمة سوقية تقارب ١١٫٤ مليار US$. تراوح نطاق التداول خلال 52 أسبوعًا بين ١٥٢٫٣٣ US$ و٢٤٦٫٣٣ US$. تم تقييم هذا الإيداع على أنه ذو معنويات سوقية محايدة وبدرجة أهمية ٨ من 10.